| NMPA公布参比制剂 |
|---|
| 序号 |
药品通用名 |
英文名称 |
商标名 |
规格 |
剂型 |
持证商 |
备注 |
| 21-139 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex(赛机宁) |
2.5mL:5mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited |
国内上市的原研药品 |
| 21-140 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex(赛机宁) |
5mL:10mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited |
国内上市的原研药品 |
| 21-141 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex(赛机宁) |
10mL:20mg |
注射剂 |
The Wellcome Foundation Limited/Aspen Pharma Trading Limited |
国内上市的原研药品 |
| 22-495 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex Preservative Free |
5mL:10mg |
注射剂 |
AbbVie Inc |
未进口原研药品 |
| 22-496 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex Preservative Free |
20mL:200mg |
注射剂 |
AbbVie Inc |
未进口原研药品 |
| 21-215 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex |
2.5mL:5mg |
注射剂 |
The Wellcome Foundation Limited/ Aspen Pharma Trading Limited |
原研进口 |
| 21-216 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex |
5mL:10mg |
注射剂 |
The Wellcome Foundation Limited/ Aspen Pharma Trading Limited |
原研进口 |
| 21-217 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex Preservative Free |
5mL:10mg |
注射剂 |
AbbVie Inc |
美国橙皮书 |
| 21-218 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex |
10mL:20mg |
注射剂 |
The Wellcome Foundation Limited/ Aspen Pharma Trading Limited |
原研进口 |
| 21-219 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex Preservative Free |
20mL:200mg |
注射剂 |
AbbVie Inc |
美国橙皮书 |
| 32-23 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex |
2.5ml:5mg |
注射剂 |
Aspen Pharma Trading Limited |
未进口原研药品 |
| 32-57 |
苯磺顺阿曲库铵注射液 |
Cisatracurium Besylate Injection |
Nimbex |
2.5ml:5mg |
注射剂 |
Aspen Pharma Trading Limited |
未进口原研药品 |
